Full Text (PDF)
Original Article

Studies on 1-(2, 4-Dimethoxy-5-[3-(Substituted-Phenyl)Acryloyl]Phenyl)-4- (Substituted-Phenyl)But-2-En-1-Ones

Asif Husain , Asif Husain

Author Information

Licence:



Journal of Pharmaceutical and Medicinal Chemistry 1(2):p 85-89, . | DOI:
How Cite This Article:

Received : N/A         Accepted : N/A          Published : N/A

Abstract

 A series of 1-(2, 4-dimethoxy-5-[3-(substituted-phenyl)acryloyl]phenyl)-4-(substituted-phenyl)but-2-en-1-ones (3a-e) were synthesized and evaluated for their antimicrobial actions. Resorcinol was used as starting material for the preparation of 1, 1´-(4, 6-dihydroxy-1, 3-phenylene) diethanone (1), which then treated with dimethylsulphate to obtain 1-(5-acetyl-2, 4-dimethoxyphenyl)-1-ethanone (2). Compound (2) was reacted with substituted aromatic aldehydes in ethanol in presence of KOH to furnish the title compounds (3a-e). The structures of the synthesized compounds were confirmed on the basis of  1H-NMR, Mass and elemental analysis results. The antimicrobial activity (minimum inhibitory concentration; MIC) of the title compounds was determined against some selected bacterial and fungal strains. Two compounds, 3d and 3e, showed good antimicrobial activity against S. aureus and E. coli.

Keywords: Chalcone; MIC; Antibacterial; Antifungal.


References (Bibliographical note)

No records found.


Funding Details


Author Information

Authors and Affiliatione

  • Asif Husain
    ,
  • Asif Husain
    ,

Rights & Permissions



About this article


Cite this article


Licence:



Download citation

Received Accepted Published
N/A N/A N/A
DOI:

Keywords

Search for Similar Articles

You may search for similar articles that contain these



Article Level Metrics

Last Updated

Saturday 19 April 2025, 05:13:14 (IST)


1

Accesses

00
0
00

Citations


22
11
23

View full article metrics including social shares, article views and publishing history


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article




Share